THE Royal Pharmaceutical Society (RPS) in Scotland has welcomed the imminent start of the minor ailments service (MAS) pilot in Inverclyde, which extends the current MAS to all patients registered with a GP practice in Inverclyde, and will include treatments for the most common, uncomplicated conditions which normally require a GP prescription.
The Scottish Government Circular PCA (P)(2017) 2 outlines the arrangements for scheme, which is due to start on January 30.
Alex MacKinnon, Director for Scotland, said: “This was one of our key asks in our parliamentary manifesto ahead of the elections last year, and I am delighted to see this pilot getting underway. I look forward to hearing more as it is rolled out and seeing the results of its evaluation.”
The extended MAS will be piloted and evaluated as part of a whole systems approach to primary care transformational change within the Inverclyde Health and Social Care Partnership area. Patients in Inverclyde who are not eligible for the extended MAS pilot can continue to access the national MAS, if they meet the eligibility criteria for that service, which is unchanged.